ETONEton Pharmaceuticals, Inc.
$54.73+159% 1Y
$54.73
$14.3552 weeks$64.38
What is the market doing?
Mixed
1 neutral, 2 without dataRangebound. That is the only one of 3 checks this filer's data supports, so take it as a single data point rather than a settled answer.
TrendRangeboundderived · Oct 8, 2026
Choppy, but holding above its 200-day average. Price is +66% vs its 200-day average.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ETON is trading
Eton Pharmaceuticals, Inc. is +159% over the past year while the S&P 500 is +18%: 141 points ahead of the market.
+159%
1-year return · S&P 500 +18%
- vs 200-day average
- +66%
vs 200-day average · a clear uptrend
- RSI (14)
- 48
RSI (14) · neutral
- Below its 52-week high
- 15%
Below its 52-week high
Details›
- Last close2026-10-08
- $54.73
- 1 monthS&P 500 +1.6%
- −6.9%
- 1 yearS&P 500 +18%
- +159%
- 5 yearsS&P 500 +86%
- +986%
- vs 50-day average$55.40
- −1.2%
- 52-week high
- $64.38
- 52-week low
- $14.35
- Annualised volatility
- 67%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- −$8.7M
| Year | Return |
|---|---|
| 2026 (year to date) | +224% |
| 2025 | +27% |
| 2024 | +204% |
| 2023 | +55% |
| 2022 | −34% |
| 2021 | −47% |
| 2020 | +13% |
| 2019 | +18% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 8 | 4 of 8 | +5.0% |
| Feb | 8 | 4 of 8 | +0.75% |
| Mar | 8 | 4 of 8 | +0.08% |
| Apr | 8 | 3 of 8 | +4.1% |
| May | 8 | 5 of 8 | +1.9% |
| Jun | 8 | 2 of 8 | −4.4% |
| Jul | 8 | 4 of 8 | +0.41% |
| Aug | 8 | 6 of 8 | +17% |
| Sep | 8 | 4 of 8 | +4.5% |
| Oct | 8 | 5 of 8 | +6.7% |
| Nov | 7 | 4 of 7 | +5.1% |
| Dec | 8 | 5 of 8 | +5.2% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers, Specialty & Generic
Ranks #34 of 41 by RyuScore